ibrutinib and bleeding risk
Anyone familiar with this medication? Used for some lymphomas and leukemia, apparently some higher bleeding risk. It affects platelet function. UptoDate says risks/benefits of holding 3-7 days.
I have a patient on this scheduled for TFESI so thinking of just continuing (recently started doing these on blood thinners). If ILESI I think I would send note to oncologist to stop 5-7 days.
Thoughts?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: ragnathor Tags: Pain Medicine Source Type: forums
More News: Bleeding | Cancer & Oncology | Leukemia | Lymphoma | Pain | Students | Universities & Medical Training